BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31990679)

  • 1. Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure.
    Heidemann S; Bursic B; Zandi S; Li H; Abelson S; Klaassen RJ; Abish S; Rayar M; Breakey VR; Moshiri H; Dhanraj S; de Borja R; Shlien A; Dick JE; Dror Y
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31990679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal architecture of secondary acute myeloid leukemia.
    Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
    N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonality studies and N-ras and p53 mutation analysis of hematopoietic cells in Fanconi anemia.
    Venkatraj VS; Gaidano G; Auerbach AD
    Leukemia; 1994 Aug; 8(8):1354-8. PubMed ID: 8057673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations and clonal hematopoiesis in congenital neutropenia.
    Xia J; Miller CA; Baty J; Ramesh A; Jotte MRM; Fulton RS; Vogel TP; Cooper MA; Walkovich KJ; Makaryan V; Bolyard AA; Dinauer MC; Wilson DB; Vlachos A; Myers KC; Rothbaum RJ; Bertuch AA; Dale DC; Shimamura A; Boxer LA; Link DC
    Blood; 2018 Jan; 131(4):408-416. PubMed ID: 29092827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
    Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
    Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mourad S; Bilodeau M; Roussy M; Laramée L; Boulianne L; Rouette A; Jouan L; Gendron P; Duval M; Teira P; Hébert J; Bittencourt H; Pastore Y; Landry JR; Cellot S
    Front Oncol; 2019; 9():772. PubMed ID: 31475115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clones.
    Saeed BR; Manta L; Raffel S; Pyl PT; Buss EC; Wang W; Eckstein V; Jauch A; Trumpp A; Huber W; Ho AD; Lutz C
    Int J Cancer; 2021 Jun; 148(11):2825-2838. PubMed ID: 33411954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
    Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
    Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome.
    Joyce CE; Saadatpour A; Ruiz-Gutierrez M; Bolukbasi OV; Jiang L; Thomas DD; Young S; Hofmann I; Sieff CA; Myers KC; Whangbo J; Libermann TA; Nusbaum C; Yuan GC; Shimamura A; Novina CD
    J Clin Invest; 2019 Jun; 129(9):3821-3826. PubMed ID: 31211692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
    Calleja A; Yun S; Moreilhon C; Karsenti JM; Gastaud L; Mannone L; Komrokji R; Al Ali N; Dadone-Montaudie B; Robert G; Auberger P; Raynaud S; Sallman DA; Cluzeau T
    Eur J Haematol; 2020 May; 104(5):488-498. PubMed ID: 31990086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.
    Mehta PA; Harris RE; Davies SM; Kim MO; Mueller R; Lampkin B; Mo J; Myers K; Smolarek TA
    Cancer Genet Cytogenet; 2010 Dec; 203(2):180-6. PubMed ID: 21156231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study.
    Dror Y; Durie P; Ginzberg H; Herman R; Banerjee A; Champagne M; Shannon K; Malkin D; Freedman MH
    Exp Hematol; 2002 Jul; 30(7):659-69. PubMed ID: 12135662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemia.
    Shibata S; Inano S; Watanabe M; Fujiwara K; Ueno H; Nannya Y; Kanda J; Kawasaki N; Okamoto Y; Takiuchi Y; Fukunaga A; Tabata S; Ogawa S; Takaori-Kondo A; Kitano T
    Int J Hematol; 2022 Mar; 115(3):428-434. PubMed ID: 34704233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fanconi anemia and the development of leukemia.
    Alter BP
    Best Pract Res Clin Haematol; 2014; 27(3-4):214-21. PubMed ID: 25455269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA; Ferguson W; Mark HF
    Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-Sensitive
    Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
    Front Immunol; 2019; 10():116. PubMed ID: 30891028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
    Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
    Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anemia and clonal evolution: germ line and somatic genetics.
    Shimamura A
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):74-82. PubMed ID: 27913465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.